Selzentry (Maraviroc, Celsentri): News & Research
- Maraviroc Does Not Prevent Immune Reconstitution Syndrome (Video) (March 24, 2013)
From HIVandHepatitis.com
- Maraviroc Plus Atazanavir/Ritonavir in a Nuke-Sparing Regimen in Treatment-Naive Patients (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- High Levels of Maraviroc in Rectal Tissue Fail to Protect Macaques From SIV Transmission Following Rectal Exposure (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- AIDS 2012: Other Treatment Studies (August 1, 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- FDA Approves New Medication for HIV Prevention Study (July 20, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Conference Update From IAS 2011: Medication News (September/October 2011)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Paediatric Antiretroviral Pipeline: Update on Etravirine and Maraviroc (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Maraviroc Plus Atazanavir/r Without Nukes Versus Standard of Care: 48-Week Results (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Selzentry Reduces Liver Stiffness in HIV/HCV-Coinfected Patients (July 21, 2011)
From AIDSmeds.com
- Maraviroc Improves Liver Fibrosis in HIV/Hepatitis C Co-Infected Patients (July 20, 2011)
From aidsmap.com
- Etravirine Lowers Levels of Maraviroc Given at 300 or 600 mg Twice Daily (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Once-Daily 150-mg Maraviroc Explored in People Taking Atazanavir/Ritonavir (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Indian Drugmaker Seeks to Make, Sell Generic Version of Pfizer's HIV Drug (January 5, 2011)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Long-Term Outcomes Good After Coreceptor Switch in Maraviroc Failure (September 15, 2010)
From National AIDS Treatment Advocacy Project
- People With X4 Virus Who Failed Selzentry Have Good Long-Term Results (September 14, 2010)
From AIDSmeds.com
- Small Study Suggests Once-Daily MVC Plus ATV/r as Viable First Regimen (July 26, 2010)
From National AIDS Treatment Advocacy Project
- Fewer Malignancies Seen in Those Taking Selzentry (July 20, 2010)
From AIDSmeds.com
- Selzentry Labeling Includes New Warnings for People With Kidney Problems: A Blog Entry by Myles Helfand (June 2, 2010)
From TheBody.com
- Selzentry (Maraviroc) 150 mg and 300 mg Tablets, Labeling Changes for Patients With Renal Impairment (June 1, 2010)
From U.S. Food and Drug Administration
- Maraviroc Approved for First-Line Therapy (Winter/Spring 2010)
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Maraviroc Showing Tantalising Promise as Microbicide in Preclinical Studies (February 19, 2010)
From aidsmap.com
|
Advertisement
|
Email
Glossary
